Commercially Available Preparations of Recombinant Wnt3a Contain Non-Wnt Related Activities Which May Activate TGF-β Signaling

Journal of Cellular Biochemistry

Volumn 117, Issue 4, 2016, Pages 938-945

  Carthy, Jon M ^a   Engström, Ulla ^a   Heldin, Carl Henrik ^a   Moustakas, Aristidis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

BMP; FIBROBLAST; SMAD; TGF ; Wnt; Wnt3a

Indexed keywords

BETA CATENIN; RECOMBINANT PROTEIN; RECOMBINANT WNT3A PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT3A PROTEIN; 2-PHENYL-4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)PYRIDINE; BMP7 PROTEIN, MOUSE; CTNNB1 PROTEIN, MOUSE; DMH1 COMPOUND; FRIZZLED RELATED PROTEIN-1; NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; PROTEIN; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; QUINOLINE DERIVATIVE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WNT3A PROTEIN, MOUSE;

ARTICLE; CELL CULTURE; FIBROBLAST; FOLLOW UP; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MAMMAL CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; 3T3 CELL LINE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTIFACT; BIOTECHNOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PROCEDURES; QUALITY CONTROL; STANDARDS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ARTIFACTS; BETA CATENIN; BIOTECHNOLOGY; BONE MORPHOGENETIC PROTEIN 7; GENE EXPRESSION REGULATION; MICE; NIH 3T3 CELLS; PROTEINS; PYRAZOLES; PYRIDINES; QUALITY CONTROL; QUINOLINES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; WNT3A PROTEIN;

EID: 84958205983     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25378     Document Type: Article

References (25)

1. Ao A, Hao J, Hopkins C R, Hong C C,. 2012. DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. PLoS ONE 7: e41627.
2. Cajanek L, Adlerz L, Bryja V, Arenas E,. 2010. WNT unrelated activities in commercially available preparations of recombinant WNT3a. J Cell Biochem 111: 1077-1079.
3. Carthy JM, Sundqvist A, Heldin A, van Dam H, Kletsas D, Heldin CH, Moustaka A,. 2015. Tamoxifen inhibits TGF-β-mediated activation of myofibroblasts by blocking non-smad signaling through ERK1/2. J Cell Physiol 230: 3084-3092.
4. Carthy JM, Garmaroudi FS, Luo Z, Mcmanus BM,. 2011. Wnt3a induces myofibroblast differentiation by upregulating TGF-β signaling through SMAD2 in a beta-catenin-dependent manner. PLoS ONE 6: e19809.
5. Carthy JM, Luo Z, Mcmanus BM,. 2012. WNT3A induces a contractile and secretory phenotype in cultured vascular smooth muscle cells that is associated with increased gap junction communication. Lab Invest 92: 246-255.
6. Clevers H, Nusse R,. 2012. Wnt/β-catenin signaling and disease. Cell 149: 1192-1205.
7. Dalton S,. 2013. Signaling networks in human pluripotent stem cells. Curr Opin Cell Biol 25: 241-246.
8. Daly AC, Randall RA, Hill CS,. 2008. Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28: 6889-6902.
9. De Gouville AC, Boullay V, Krysa G, Pilot J, Brusq JM, Loriolle F, Gauthier JM, Papworth SA, Laroze A, Gellibert F, Huet S,. 2005. Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 145: 166-177.
10. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C,. 1998. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391: 357-362.
11. Gordon MD, Nusse R,. 2006. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429-22433.
12. Jamieson C, Sharma M, Henderson BR,. 2014. Targeting the β-catenin nuclear transport pathway in cancer. Semin Cancer Biol 27: 20-29.
13. Kang Y, Chen CR, Massague J,. 2003. A self-enabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11: 915-926.
14. Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, Wang XF,. 2009. TGF-β-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J 28: 88-98.
15. Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Eimon PM, Harland RM, Warman ML,. 2001. Human disease-causing NOG missense mutations: Effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci USA 98: 11353-11358.
16. Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS,. 2012. Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science 338: 108-113.
17. Moustakas A, Heldin CH,. 2007. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
18. Niehrs C,. 2010. On growth and form: A Cartesian coordinate system of Wnt and BMP signaling specifies bilaterian body axes. Development 137: 845-857.
19. Rahman-Roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, Becker S, Hirschberg D, Jornvall H, Auer G, Wiman KG,. 2007. P53 targets identified by protein expression profiling. Proc Natl Acad Sci USA 104: 5401-5406.
20. Razmara M, Eger G, Rorsman C, Heldin CH, Lennartsson J,. 2012. MKP3 negatively modulates PDGF-induced Akt and Erk5 phosphorylation as well as chemotaxis. Cell Signal 24: 635-640.
21. Sanchez-Guerrero E, Jo SR, Chong BH, Khachigian LM,. 2013. EGFR and the complexity of receptor crosstalk in the cardiovascular system. Curr Mol Med 13: 3-12.
22. Schulte G, Bryja V, Rawal N, Castelo-Branco G, Sousa KM, Arenas E,. 2005. Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem 92: 1550-1553.
23. Sousa KM, Villaescusa JC, Cajanek L, Ondr JK, Castelo-Branco G, Hofstra W, Bryja V, Palmberg C, Bergman T, Wainwright B, Lang RA, Arenas E,. 2010. Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem 285: 7246-7253.
24. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR, 3rd, Nusse R,. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
25. Wrighton KH, Lin X, Yu PB, Feng XH,. 2009. Transforming Growth Factor {beta} Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors. J Biol Chem 284: 9755-9763.